Diffusion of metronidazole released from aqueous solution and a gel through human and rabbit corneas

Journal of Ocular Pharmacology and Therapeutics

Volumn 20, Issue 5, 2004, Pages 421-429

  Van Der Bijl, Pieter ^a,b   Van Eyk, Armorél D ^a   Seifart, Heiner I ^a   Meyer, David ^b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; METRONIDAZOLE; TEARGEL;

ACANTHAMOEBA KERATITIS; ADULT; ANALYSIS OF VARIANCE; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA; DRUG DIFFUSION; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; EYEBANK; FLOW MEASUREMENT; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; NONHUMAN; NONLINEAR REGRESSION ANALYSIS; RABBIT; STEADY STATE;

ADULT; AGED; ANIMALS; ANTIPROTOZOAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORNEA; DIFFUSION; DRUG DELIVERY SYSTEMS; GELS; HUMANS; METRONIDAZOLE; MIDDLE AGED; PERMEABILITY; RABBITS; SOLUTIONS;

EID: 7444231480     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2004.20.421     Document Type: Article

References (17)

1. Van der Bijl, P., Van Eyk, A.D., Seifart, H.I., et al. In vitro transcorneal penetration of metronidazole and its potential use as adjunct therapy in Acanthamoeba keratitis. Cornea (in press), 2004.
2. Maudgal, P.C. Acanthamoeba keratitis: Report of three cases. Bull. Soc. Belge Ophthalmol. 231:135-148, 1989.
3. Sharma, S., Srinivasan, M., and George, C. Diagnosis of Acanthamoeba keratitis: A report of four cases and review of literature. Indian J. Ophthalmol. 38:50-56, 1990.
4. Draulans, E., and Maudgal, P.C. Acanthamoeba keratitis. Bull. Soc. Belge Ophthalmol. 243:115-128, 1992.
5. Yeung, E.Y., Huang, S.C.M., and Tsai, R.J.F. Acanthamoeba keratitis presenting in a soft contact lens wearer. Chang Gung Med. J. 25:201-206, 2002.
6. Reuber, H., and Koch, J.M. Acanthamoeba keratitis caused by extended wear contact lenses [translation]. Klin. Monatsbl. Augenheilk. 200:48-50, 1992.
7. Horne, D.D., Frizell, M.E., Ingham, L., et al. Acanthamoeba keratitis: An emerging clinical problem. CMAJ 150:923-925, 1994.
8. Yanoff , M., and Fine, B.S. Ocular Pathology, 4th ed. London: Mosby-Wolfe, 1996:247.
9. Budavari, S., ed. The Merck Index, 12th ed. Whitehouse Station, NJ: Merck Research Laboratories, Merck & Co., Inc., 1996:6243.
10. Van der Bijl, P., Van Eyk, A.D., and Meyer, D. Effects of three penetration enhancers on transcorneal permeation of cyclosporine. Cornea 20:505-508, 2001.
11. Van der Bijl, P., Engelbrecht, A.H., Van Eyk, A.D., et al. Comparative permeability of human and rabbit corneas to cyclosporin and tritiated water. J. Ocular Pharmacol. Ther. 18:419-427, 2002.
12. Motulsky, H. Intuitive biostatistics. In: President, Graphpad Software. New York: Oxford University Press, 1995.
13. Higuchi, W.I. Analysis of data on the medicament release from ointments. J. Pharm. Sci. 51:802-804, 1962.
14. Guy, R.H., and Hadgraft, J. On the determination of drug release rates from topical dosage forms. In. J. Pharm. 60:R1-R3, 1990.
15. Rahman, M.S., Babar, A., Patel, N.K., et al. Medicament release from ointment bases. V. Naproxen in vitro release and in vivo percutaneous absorption in rabbits. Drug. Dev. Ind. Pharm. 16:651-672, 1990.
16. Squier, C.A. The permeability of oral mucosa. Crit. Rev. Oral Biol. Med. 2:13-32, 1991.
17. Grass, G.M., and Robinson, J.R. Relationship of chemical structure to corneal penetration and influence of low-viscosity solution on ocular bioavailability. J. Pharm. Sci. 73:1021-1027, 1984.